Kailey Paglia is an associate in the London office of Wilson Sonsini Goodrich & Rosati, where she is dually qualified as an attorney in New York and as a Solicitor of England and Wales. She has represented both investor- and company-side interests in venture transactions, both in the United States and Europe.
Kailey's clients have been companies at all stages of growth, and investors ranging from angels through to institutional investors. She also has experience in assisting foreign companies as they look to expand to the United States.
Kailey Paglia is an associate in the London office of Wilson Sonsini Goodrich & Rosati, where she is dually qualified as an attorney in New York and as a Solicitor of England and Wales. She has represented both investor- and company-side interests in venture transactions, both in the United States and Europe.
Kailey's clients have been companies at all stages of growth, and investors ranging from angels through to institutional investors. She also has experience in assisting foreign companies as they look to expand to the United States.
- LL.M., International and Comparative Law, Trinity College Dublin, 2016
- J.D., Indiana Maurer School of Law, 2016
- BSPA, Environmental Management, Indiana University, Bloomington
- State Bar of New York
- Solicitor, England and Wales
- LL.M., International and Comparative Law, Trinity College Dublin, 2016
- J.D., Indiana Maurer School of Law, 2016
- BSPA, Environmental Management, Indiana University, Bloomington
- State Bar of New York
- Solicitor, England and Wales
The combination of the two digital therapeutic companies creates the largest VR delivery platform for evidence-based digital behavioral therapies and accelerates the combined company’s growth strategy. Operating under the BehaVR brand, the comprehensive VR treatment platform will help providers, payers, and employers deliver and increase access to enhanced behavioral care.
The Wilson Sonsini team that advised Optum Ventures and Oxford Science Enterprises on the transaction included:
- Privacy Policy
- Terms of Use
- Accessibility